A Single-tube Assay for Detecting ALK, ROS1 and RET Fusions in Lung Cancer
Maruja Lira, Pfizer Inc, speaking at Point-of-Care Diagnostics World Congress 2013.
Date Posted: Thursday, November 14, 2013
Pfizer, Adaptive Biotechnologies Collaborate Pfizer Inc. and Adaptive Biotechnologies Corporation have entered into a translational research collaboration to leverage next generation sequencing of the adaptive immune system to advance Pfizer’s growing immuno-oncology franchise. Monday, January 11, 2016